Otsuka (OTCMKTS:OTSKY) Sees Large Volume Increase – Should You Buy?

Shares of Otsuka Holdings Co., Ltd. – Unsponsored ADR (OTCMKTS:OTSKY) saw unusually-high trading volume on Thursday . Approximately 399,920 shares were traded during trading, an increase of 921% from the previous session’s volume of 39,160 shares.The stock last traded at $36.04 and had previously closed at $34.88.

Otsuka Stock Performance

The company has a debt-to-equity ratio of 0.05, a current ratio of 2.21 and a quick ratio of 1.65. The stock has a 50-day simple moving average of $36.83 and a 200-day simple moving average of $35.19. The stock has a market cap of $37.95 billion, a P/E ratio of 14.19, a PEG ratio of 2.59 and a beta of 0.01.

Otsuka (OTCMKTS:OTSKY) last posted its earnings results on Friday, July 31st. The company reported $0.70 EPS for the quarter, topping analysts’ consensus estimates of $0.51 by $0.19. Otsuka had a net margin of 15.50% and a return on equity of 12.86%. The firm had revenue of $4.41 billion during the quarter, compared to analysts’ expectations of $3.95 billion. Otsuka has set its FY 2026 guidance at 2.119-2.119 EPS. Research analysts forecast that Otsuka Holdings Co., Ltd. – Unsponsored ADR will post 2.23 earnings per share for the current year.

Otsuka Company Profile

Otsuka Holdings Co, Ltd. is a Japan-based healthcare and consumer products group whose businesses span pharmaceuticals, nutraceuticals and consumer health products, as well as related medical and chemical activities. The company operates primarily through subsidiaries including Otsuka Pharmaceutical Co, Ltd. and serves customers in Japan and international markets.

Otsuka’s pharmaceutical operations focus on prescription medicines in areas such as psychiatry, oncology, nephrology, cardiovascular disease and several other therapeutic fields.